Trials / Recruiting
RecruitingNCT04690348
Intracavitary Carrier-embedded Cs131 Brachytherapy for Recurrent Brain Metastases: a Randomized Phase II Study
- Status
- Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 103 (estimated)
- Sponsor
- Memorial Sloan Kettering Cancer Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to see if Cs-131 brachytherapy is effective in people with recurrent brain cancer who are scheduled to have brain surgery for removal of their tumor(s). The researchers would like to see whether Cs-131 prevents brain tumors from growing back after surgery.The researchers will compare Cs-131 brachytherapy (which occurs during brain surgery) with the usual approach of brain surgery without brachytherapy. The researchers will compare both the effectiveness and safety of the two approaches.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Craniotomy | Craniotomy |
| RADIATION | Cesium-131 brachytherapy | Intracavitary Cesium-131 brachytherapy |
Timeline
- Start date
- 2020-12-24
- Primary completion
- 2026-12-01
- Completion
- 2026-12-01
- First posted
- 2020-12-30
- Last updated
- 2026-01-13
Locations
6 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04690348. Inclusion in this directory is not an endorsement.